ABPWW Stock Price, Chart, Stats & News

Abpro Holdings Inc. is a biotechnology firm dedicated to creating sophisticated antibody-based treatments for individuals grappling with immuno-oncology, ophthalmology, and autoimmune disorders. The company's innovative DiversImmune platform is specifically engineered to resolve a key hurdle currently facing the antibody therapeutics sector. Among its leading experimental therapies are ABP-100, designed to combat breast, gastric, and colorectal cancers, and ABP-201, aimed at treating vascular conditions affecting the eye.